Related Articles
Should SSRIs Carry a Black Box Warning in Pregnancy? FDA Panel Sparks Controversy
🗓️ Context & Timeline From July 21 to 25, 2025, the U.S. Food and Drug Administration convened a 10‑member expert panel to evaluate the safety…
Viloxazine: Non-Stimulant Medication now FDA Approved for Adult ADHD
Viloxazine ER (Qelbree) was initially approved for pediatric ADHD and now had received FDA approval for the management of ADHD in adult patients. We have…
ADHD Treatment During Pregnancy: What the Latest Evidence Means for Mothers and Clinicians
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list 📊 Poll for Clinicians: We’d love to…
Managing Clozapine Adverse Events
PSYCHIATRY EDUCATION FORUM ACADEMY’S MANAGING CLOZAPINE ADVERSE EVENTS UNDERSTANDING THE BASICS & BEYOND Introduction: Clozapine was FDA-approved for treatment-refractory schizophrenia in 1989 and has remained…
Top 10 Viewed Posts in 2022
As we approach the end of 2022, I want to wish you all a safe and Happy New Year. Hope this new year makes all…